top of page

Home: Welcome
We are a start-up committed to making precision medicine a living reality for the multi-modal (medication & non-medication) treatment of ADHD.
​
We use AI methods to map together elements, including clinical factors, genes and environment. We transform multi-dimensional data into prediction models of which treatment plan is likely to work best for each individual.
​
Are we there yet? Still at the stage of refining our prediction models, we are working closely with clinicians and individuals with lived experience. While in process, we have been actively involved in sharing the latest science and building awareness.
Core to everything we do is honest, interpretable AI and most importantly, the human connection!​
Home: Contact
AIMH in print
ADHD in individuals over the age of 50 is often overlooked, or mistaken for mild cognitive impairment....
Read the article published in Unison News.
By Venture for Cananda (VFC) intrapreneur, Sebastian White.
Collaborative work, together with Communications Director Mel Lefebvre & CEO Sarojini Sengupta.
ADHD & procrastination
By VFC intrapreneur Mujtaba Kureshi, Mel & Sarojini.
Unravelling the complexity of ADHD
By Mel & Sarojini
ADHD is often missed in girls and women
By Mel & Sarojini
Increasing awareness of ADHD in the Indian subcontinent...
By Mel & Sarojini
AI: a tool in clinical practise and ADHD research
Read our article in the CADDRA ADHD Research Digest
By CSO Tyler Bonnell & Sarojini
Visit here for the interview of how things all began at AIMH!
Sharing a glimpse of the entrepreneurial journey, together with other entrepreneurs.
Collaboration with IVADO
bottom of page







